HIGHLIGHTS
- who: Yanfang Zhang and colleagues from the Nanjing Medical University, China have published the article: Immune-related adverse events correlate with the efficacy of PD-1 inhibitors combination therapy in advanced cholangiocarcinoma patients: A retrospective cohort study, in the Journal: (JOURNAL)
- what: The results of this study showed that among CCA patients receiving PD1 inhibitors combination therapy, the irAEs cohort had a higher Frontiers in Immunology frontiersin.org 10.3389/fimmu.2023.1141148 Treatment strategy Combine with chemotherapy Reference Reference Combine with multi-target TKIs Combine with chemotherapy and multi-target TKIs irAEs (yes vs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.